(Q50066851)

24 February 2018

title

Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle. (English)

1 reference

24 February 2018

0 references

1 reference

Salmonella Typhimurium

object named as

Salmonella typhimurium

1 reference

Aws Abdul-Wahid

1

1 reference

24 February 2018

Gaétan Faubert

series ordinal

2

1 reference

24 February 2018

language of work or name

English

0 references

publication date

24 October 2007

1 reference

24 February 2018

published in

Vaccine

1 reference

24 February 2018

volume

25

1 reference

24 February 2018

issue

50

1 reference

24 February 2018

page(s)

8372-8383

1 reference

24 February 2018

Giardia muris: correlation between oral dosage, course of infection, and trophozoite distribution in the mouse small intestine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Giardiasis in dairy calves: effects of fenbendazole treatment on intestinal structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Giardia infection in farm animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Prevalence and genotypes of Giardia duodenalis in 1-2 year old dairy cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Prevalence and molecular characterization of Cryptosporidium and Giardia species and genotypes in sheep in Maryland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Update on Cryptosporidium and Giardia infections in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

UV disinfection of Giardia lamblia cysts in water

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Oral Immunization of BALB/c Mice with Giardia duodenalis Recombinant Cyst Wall Protein Inhibits Shedding of Cysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Recognition of Giardia lamblia cyst-specific antigens by monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Identification of a novel Giardia lamblia cyst wall protein with leucine-rich repeats. Implications for secretory granule formation and protein assembly into the cyst wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Active and passive mechanisms drive secretory granule biogenesis during differentiation of the intestinal parasite Giardia lamblia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Dephosphorylation of cyst wall proteins by a secreted lysosomal acid phosphatase is essential for excystation of Giardia lamblia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Expression of the Giardia lamblia cyst wall protein 2 in Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Oral immunization of BALB/c mice by intragastric delivery of Streptococcus gordonii-expressing Giardia cyst wall protein 2 decreases cyst shedding in challenged mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

DNA vaccines and their application against parasites--promise, limitations and potential solutions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

DNA vaccines: immunology, application, and optimization*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Bacteria-mediated DNA transfer in gene therapy and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Transfer of eukaryotic expression plasmids to mammalian hosts by attenuated Salmonella spp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Oral somatic transgene vaccination using attenuated S. typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Delivery of a heterologous antigen by a registered Salmonella vaccine (STM1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Gene delivery by attenuated Salmonella typhimurium: comparing the efficacy of helper versus cytotoxic T cell priming in tumor vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Systemic and mucosal immunity induced by oral somatic transgene vaccination against glycoprotein B of pseudorabies virus using live attenuated Salmonella typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Three-phase partitioning as an efficient method for extraction/concentration of immunoreactive excreted-secreted proteins of Corynebacterium pseudotuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Exogenous cytokines released by spleen and Peyer's patch cells removed from mice infected with Giardia muris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

T-cell-dependent control of acute Giardia lamblia infections in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Recognition of pathogen-associated molecular patterns by TLR family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Central importance of immunoglobulin A in host defense against Giardia spp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Cytokines in host defense against Salmonella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Giardia induces proliferation and interferon gamma production by intestinal lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Immune response to Giardia duodenalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

Longitudinal studies of Giardia contamination in two community drinking water supplies: cyst levels, parasite viability, and health impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

7 January 2021

Risk factors for Giardia intestinalis infection in agricultural villages practicing wastewater irrigation in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

7 January 2021

Studies of Giardia spp. and Cryptosporidium spp. in two adjacent watersheds.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

7 January 2021

Comparison of antibody and cytokine responses to primary Giardia muris infection in H-2 congenic strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.012

7 January 2021

10.1016/J.VACCINE.2007.10.012

Identifiers

DOI

1 reference

24 February 2018

1 reference

24 February 2018